David Hung Insider Trading $AXON Sio Gene Therapies Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Hung.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Hung. David Hung is President and CEO in MEDIVATION, INC. ($MDVN) and Principal Executive Officer in Axovant Sciences Ltd. ($AXON) and Director in NovoCure Ltd ($NVCR) and Director in ESTABLISHMENT LABS HOLDINGS INC. ($ESTA) and Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA) and President and CEO in Nuvation Bio Inc. ($PANA).

David Hung in Sio Gene Therapies Inc.

Trading Symbol: AXON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hung: Principal Executive Officer
Holdings: 539,375 shares
Current Value: $6,995,694
Latest Transaction: Jan 03 2018
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David Hung in Sio Gene Therapies Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARYA, ESTA, MDVN, NVCR, NUVB, AXON

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 03 2018	AXON	Axovant Sciences L ...	Hung David	Principal Executive ...	Option Exercise	M	5.27	2,000,000	10,540,000	2,000,000
Apr 19 2017	AXON	Axovant Sciences L ...	Hung David	Principal Executive ...	Buy	P	18.54	539,375	10,000,013	539,375	0 to 539.4 K
Apr 11 2017	AXON	Axovant Sciences L ...	Hung David	Principal Executive ...	Option Exercise	A	15.13	2,000,000	30,260,000	2,000,000
Apr 11 2017	AXON	Axovant Sciences L ...	Hung David	Principal Executive ...	Option Exercise	A	15.13	2,000,000	30,260,000	2,000,000

Page: 1